Rigshospitalet
Copenhagen, Denmark
NCT Number: NCT04508270
The main endpoint is physiological rehabilitation after VATS-L under early mobilization. The secondary endpoints are exploring the effect of early mobilization on postoperative physiology.
Investigators hypothesis that early mobilization is clearly advantaged to advance the physiological recovery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Copenhagen, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mobilization as soon as patients can, which is not limited on walking
Time frame: Through study completion, an average of 3 days
FEV1 is the amount of air you can force from your lungs in one second. Participants will be examed via spirometer.
Time frame: Through study completion, an average of 3 days
Oxygen saturation is the fraction of oxygen-saturated hemoglobin relative to total hemoglobin (unsaturated + saturated) in the blood. Participants will be tested via oximeter.
Time frame: Through study completion, an average of 3 days
Time frame: Through study completion, an average of 3 days
The numeric rating scale (NRS) ranging from 0 (no pain) to 10 (excruciating pain) is used to score postoperative pain.
Time frame: Through study completion, an average of 3 days
Time frame: Through study completion, an average of 2 days
Time frame: up to 30 days
Pneumothorax, subcutaneous emphysema, pneumonia, empyema, bleeding, pulmonary embolism, prolong air leakage, re-intervention, re-surgery and re-admission will be recording specifically.
Rigshospitalet, Denmark
Other
Physiological Evidence for Early Mobilization in Thoracoscopic Lobectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05059132
Behavior, Lung Diseases
Aurora, Colorado, United States
View Trial DetailsNCT04677309
Lung Cancer, Lung Diseases
Valencia, Spain
View Trial DetailsNCT06361121
Bronchial Diseases, Bronchiectasis
Al Fayyum, Egypt
View Trial DetailsNCT03037385
Adenocarcinoma, Adenocarcinoma, Papillary
Phoenix, Arizona, United States
View Trial Details